Clene Inc. Profile Avatar - Palmy Investing

Clene Inc.

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, incl…

Biotechnology
US, Salt Lake City [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of CLNN's Analysis
CIK: 1822791 CUSIP: 185634102 ISIN: US1856341029 LEI: - UEI: -
Secondary Listings
CLNN has no secondary listings inside our databases.